Improving HAE Patient Care through an Interactive Patient Simulation Platform

Accreditation Information

Target Audience
This activity is intended for allergists, primary care physicians, emergency department physicians, physician assistants, pharmacists and other healthcare professionals who may encounter patient with hereditary angioedema.

Educational Goal
The goal of this activity is to increase the awareness as well as the understanding of hereditary angioedema by having the clinician virtually manage a patient with undiagnosed HAE 1) who presents to the emergency department with an acute facial swelling, and 2) in the follow-up of the patient once discharged from the hospital.

Learning Objectives

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and CE Symmetry. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The CMEsolutions is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1.0 contact hour (0.100 CEUs).  ACPE Program Number: 0274-9999-17-028-H04-P

Participation Requirements

  1. Complete all online activities
  2. Complete evaluation, credit request form, and download or print credit statement
  3. CMEsolutions will upload credit completion information to the CPE Monitor within six weeks following the activity. The CPE Monitor System will direct electronic data submitted by ACPE-accredited providers to ACPE and to NABP, ensuring that CPE credit is officially verified by providers. Once information is received by NABP, pharmacists and pharmacy technicians will be able to log in and access information about completed CPE activities.

Faculty and Disclosures 
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Jesse Pines, MD, MBA, MSCE
Director, Center for Healthcare Innovation and Policy Research; Professor of Emergency Medicine and Health Policy & Management, The George Washington University
Fairfax, VA
Jesse Pines has disclosed the following relevant financial interests: Abbott Point of Care-Research Support; Cepheid Inc.-Speaker’s Bureau

Marc Andrew Riedl, MD. MS
Professor and Clinical Director, UCSD Allergy & Immunology, Department of Medicine, US HAEA Angioedema Center at UCSD
San Diego, CA
Marc Riedl has disclosed the following relevant financial relationships: Dyax/Shire, CSL Behring, Ionis, Pharming, Biocryst-Study Investigator; Shire, CSL Behring, Biocryst, Ionis, Pharming, Alnylam, Adverum, Kalvista-Scientific Consulting; Shire, CSL Behring, Pharming-Speaker’s Bureau

Planner Disclosures
No member of CMEsolutions or CE Symmetry has any relevant financial relationships to disclose.

There are no registration fees for this activity.

Off-label Use
This activity may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support
There is no commercial support provided for this activity

Privacy Policy
CMEsolutions Privacy and Confidentiality Policy:
CMEsolutions can be contacted at

Initial Release Date: October 27, 2017
End Date: October 26, 2018

Software Requirements 

Windows 8 or higher
Google Chrome or Firefox
Adobe Acrobat Reader 

Mac OS 10.2.8 or higher
Adobe Acrobat Reader